ChatDocto
Find a doctor
White scored tablet

PRESSCAND PLUS 8 mg/12,5 mg

Candesartan hydrochlorothiazide · scored tablets

B/30Oral use
23,760 DTRecorded public price · B/30
See all pack prices
Strength8 mg/12,5 mg
Therapeutic classSYSTEME CARDIOVASCULAIRE

About this medicine

PRESSCAND PLUS 8 mg/12,5 mg scored tablets is listed in Tunisia's medicine catalog under the active ingredient Candesartan hydrochlorothiazide. This page brings together its recorded pack formats, prices and CNAM coverage information.

What is this medicine used for?

Review pending

A reviewed explanation of uses is not yet published for this medicine in this language. Ask a pharmacist for the leaflet for your exact product.

What side effects should I know about?

Review pending

A reviewed side-effect guide is not yet published for this medicine in this language. This does not mean that the medicine has no side effects. Read your product leaflet or ask a pharmacist.

Price by pack

Compare the recorded price for each exact pack. A catalog entry does not confirm pharmacy stock.

  • Pack · B/30

    30 units in this pack

    Recorded public price23,760 DT
    AMM No.
    9343454
    CNAM code
    303472
    CNAM reference amount
    23,580 DT

    Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

    Source recorded: August 23, 2026

    Price effective date not provided

This reference amount is not a guaranteed refund or a personal out-of-pocket estimate. Your coverage conditions must be confirmed separately.

Medicine details

Dosage formscored tablets
Route of administrationOral use
LaboratoryPHARMACARE
OriginGeneric
ScheduleA
Therapeutic classSYSTEME CARDIOVASCULAIRE

Medicines with matching catalog characteristics

These entries match the recorded ingredient, strength, form and route. This does not establish that they can replace your medicine; confirm any change with a pharmacist.

ETIKEN 8 mg/12,5 mgComprimés sécablesTAHA PHARMA · B/30
Recorded public price32,925 DT

Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

Source recorded: August 23, 2026